LEO1 Activators encompass a diverse array of chemical compounds that indirectly enhance the functional activity of LEO1, a key component of the P-TEFb complex involved in transcriptional elongation. Forskolin plays a crucial role by activating adenylate cyclase, which leads to increased cAMP levels. This elevation in cAMP enhances the activity of LEO1, facilitating more efficient transcriptional elongation. Similarly, Epigallocatechin Gallate (EGCG) indirectly augments LEO1's function by inhibiting negative regulators of transcriptional elongation, thus promoting LEO1's role within the P-TEFb complex. Another significant activator, Curcumin, modulates transcription factors and coactivators that interact with P-TEFb, thereby indirectly boosting LEO1's activity in transcriptional processes. Resveratrol contributes to LEO1 activation through sirtuin-mediated chromatin modification, enhancing LEO1's access to DNA and thus its role in transcriptional elongation.
Further contributing to the regulation of LEO1 are compounds like Trichostatin A and 5-Azacytidine. Trichostatin A, by inhibiting histone deacetylases, alters chromatin structure in a way that potentially amplifies LEO1's activity in transcriptional elongation. 5-Azacytidine, a DNA methyltransferase inhibitor, changes gene expression patterns, indirectly influencing LEO1's role within the P-TEFb complex. S-Adenosylmethionine, involved in methylation processes, and Sodium Butyrate, another histone deacetylase inhibitor, further modify the transcriptional landscape, potentially enhancing LEO1's function. Additionally, small molecule inhibitors like PD98059, LY294002, Rapamycin, and SP600125 indirectly impact LEO1 by modulating various signaling pathways that influence the transcriptional machinery. PD98059, an MEK inhibitor, LY294002, a PI3K inhibitor, Rapamycin, an mTOR inhibitor, and SP600125, a JNK inhibitor, all contribute to altering the cellular context in which LEO1 operates, thereby indirectly influencing its activity in transcriptional elongation.
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels. Elevated cAMP enhances the activity of LEO1 in the P-TEFb complex, promoting transcriptional elongation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate (EGCG) inhibits negative regulators of transcriptional elongation, thereby indirectly enhancing LEO1 activity in the P-TEFb complex. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin modulates transcription factors and coactivators interacting with the P-TEFb complex, indirectly increasing LEO1 activity and promoting transcriptional elongation. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, through sirtuin activation, modulates chromatin structure, indirectly enhancing LEO1's role in transcriptional elongation by facilitating access to DNA. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, altering chromatin structure and indirectly enhancing LEO1's activity in transcriptional elongation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine, a DNA methyltransferase inhibitor, alters gene expression patterns, indirectly influencing LEO1's role in the P-TEFb complex and transcriptional elongation. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $180.00 $655.00 | 2 | |
S-Adenosylmethionine, involved in methylation processes, indirectly influences LEO1's activity by modulating the transcriptional landscape in which LEO1 operates. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate, a histone deacetylase inhibitor, alters chromatin structure, potentially enhancing LEO1's role in transcriptional elongation by modifying the transcriptional environment. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, an MEK inhibitor, indirectly affects LEO1 by modulating signaling pathways that influence the transcriptional machinery, including the P-TEFb complex where LEO1 is active. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, alters various signaling pathways, indirectly influencing LEO1 activity in transcriptional regulation by affecting the cellular context of its action. |